Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
A recent paper by Roger Li, Urologic oncologist at Moffitt Cancer Center, was mentioned by Enrique Grande, Associate Professor at Francisco de Vitoria University, on X:
Authors: Roger Li, Patrick Hensley, Shilpa Gupta, Roger Buckley, Ashish Kamat et al.
More posts featuring Enrique Grande.
Enrique Grande, MD, PhD, MSc, is an Associate Professor at Francisco de Vitoria University. He is also an Adjunct Professor at the GU Medical Oncology Department and the Head of Oncology at MD Anderson Cancer Center.
Grande specializes in researching genitourinary and endocrine tumors and actively collaborates in developing the Translational Research and Early Drug Development Unit.
He founded the Spanish Group for Research on Orphan and Uncommon Tumors (GETHI) and serves on the Directory Board of the Spanish Task Force Group for NETs (GETNE). Dr. Grande edits several international journals and has participated in recent neuroendocrine tumor trials that led to the approval of new drugs in this field.
Dr. Roger Li is a urologic oncologist at Moffitt Cancer Center, specializing in the surgical treatment of bladder, prostate, kidney, and penile cancers. He offers open, laparoscopic, and robotic-assisted procedures, including nerve-sparing options.
Dr. Li received advanced training in urologic oncology at MD Anderson Cancer Center. Dr. Li researches personalized therapies through genomic profiling and develops new immunotherapies for early-stage bladder cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023